Limited numbers of apoptotic cells in fresh paraffin embedded bone marrow samples of patients with myelodysplastic syndrome

被引:10
作者
Brada, SJL
van de Loosdrecht, AA
Koudstaal, J
de Wolf, JTM
Vellenga, E
机构
[1] Univ Groningen Hosp, Dept Haematol, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen Hosp, Dept Pathol, Groningen, Netherlands
关键词
myelodysplastic syndrome; apoptosis; ineffective erythropoiesis; TUNEL;
D O I
10.1016/j.leukres.2004.01.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In myelodysplasia (MDS) the precise mechanism of ineffective erythropoiesis is not fully elucidated, but it is suggested that apoptosis may contribute to this process. We performed TdT-mediated dUTP-nick end labelling (TUNEL) staining of paraffin embedded bone marrow specimens to assess the amount of apoptotic cells in 21 MDS patients (7 RA, 3 RARS, 5 RAEB, 3 RAEB-T, 3 CMML) and five normal controls. In 10 MDS patients the TUNEL assay was performed in combination with immunostaining for Glycophorin-A (GpA) to determine apoptosis in the maturing erythroid compartment. To assess the proliferation of the bone marrow cells the expression of Ki-67 antigen was used as a marker. The mean apoptotic index (Al) in MDS patients was not increased (2.3 +/- 3.0% in MDS versus 4.8 +/- 1.2% in normal controls (P < 0.05)). Moreover, no significant difference in mean Al was observed in the GpA(+) compartment between MDS and normal controls (0.8 +/- 0.2% versus 0.6 +/- 0.1%). In addition the different FAB-classifications and the different International Prognostic Scoring System (IPSS)-risk groups showed no significant differences between the subgroups. The expression of Ki-67, as market for proliferative activity, in the GpA(+) compartment front MDS did not differ significantly from normal controls (84.0 +/- 12.2% versus 79.9 +/- 20.2%). Our findings suggest that the observed increased apoptosis in in vitro culture assays is related to the detachment of the cells from the microenvironment leading to an increased susceptibility to apoptosis. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:921 / 925
页数:5
相关论文
共 31 条
[1]  
ARENDS MJ, 1994, AM J PATHOL, V144, P1045
[2]  
BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x
[3]   The supportive effects of erythropoietin and mast cell growth factor on CD34(+)/CD36(-) sorted bone marrow cells of myelodysplasia patients [J].
Brada, S ;
deWolf, J ;
Hendriks, D ;
Esselink, M ;
Ruiters, M ;
Vellenga, E .
BLOOD, 1996, 88 (02) :505-510
[4]   Characterization of the erythropoiesis in myelodysplasia by means of ferrokinetic studies, in vitro erythroid colony formation and soluble transferrin receptor [J].
Brada, SJL ;
de Wolf, JTM ;
Hendriks, D ;
Louwes, H ;
van den Berg, E ;
Vellenga, E .
LEUKEMIA, 1998, 12 (03) :340-345
[5]   CD34+/CD36- cells from myelodysplasia patients have a limited capacity to proliferate but can differentiate in response to Epo and MGF stimulation [J].
Brada, SJL ;
de Wolf, JTW ;
Hendriks, DW ;
Smit, JW ;
Vellenga, E .
LEUKEMIA, 1998, 12 (06) :882-886
[6]   UNEXPECTED CYTOKINETIC EFFECTS INDUCED BY PUROMYCIN INCLUDE A G2-ARREST, A METAPHASE-MITOTIC-ARREST, AND APOPTOSIS [J].
DAVIDOFF, AN ;
MENDELOW, BV .
LEUKEMIA RESEARCH, 1992, 16 (11) :1077-1085
[7]   International scoring system for evaluating prognosis in myelodysplastic syndromes [J].
Greenberg, P ;
Cox, C ;
LeBeau, MM ;
Fenaux, P ;
Morel, P ;
Sanz, G ;
Sanz, M ;
Vallespi, T ;
Hamblin, T ;
Oscier, D ;
Ohyashiki, K ;
Toyama, K ;
Aul, C ;
Mufti, G ;
Bennett, J .
BLOOD, 1997, 89 (06) :2079-2088
[8]   Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin [J].
HellstromLindberg, E ;
KanterLewensohn, L ;
Ost, A .
LEUKEMIA RESEARCH, 1997, 21 (05) :415-425
[9]   Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome [J].
Horikawa, K ;
Nakakuma, H ;
Kawaguchi, T ;
Iwamoto, N ;
Nagakura, S ;
Kagimoto, T ;
Takatsuki, K .
BLOOD, 1997, 90 (07) :2716-2722
[10]   FLOW CYTOMETRIC DETECTION OF APOPTOSIS - COMPARISON OF THE ASSAYS OF IN-SITU DNA-DEGRADATION AND CHROMATIN CHANGES [J].
HOTZ, MA ;
GONG, JP ;
TRAGANOS, F ;
DARZYNKIEWICZ, Z .
CYTOMETRY, 1994, 15 (03) :237-244